Approval adds to the treatment options for the more than 35 million adults in the U.S. affected by chronic kidney disease (CKD) Jardiance ® (empagliflozin) 10 mg tablets significantly reduced the risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback